Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
出版年份 2016 全文链接
标题
Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
作者
关键词
Anti-IL-17, Rheumatoid arthritis, Secukinumab, Ixekizumab, Brodalumab
出版物
RHEUMATOLOGY INTERNATIONAL
Volume 36, Issue 8, Pages 1065-1075
出版商
Springer Nature
发表日期
2016-04-22
DOI
10.1007/s00296-016-3480-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- Association ofHLA-DRB1alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis
- (2015) Gerd R. Burmester et al. RHEUMATOLOGY
- Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
- (2015) Young Ho Lee et al. RHEUMATOLOGY INTERNATIONAL
- Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
- (2014) Vibeke Strand et al. Health and Quality of Life Outcomes
- Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA)
- (2014) John Maringwa et al. JOURNAL OF CLINICAL PHARMACOLOGY
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis
- (2014) Kenneth B. Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets
- (2014) D. E. Furst et al. RHEUMATOLOGY
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
- (2014) Lisa GM van Baarsen et al. ARTHRITIS RESEARCH & THERAPY
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4ig but is successfully treated by interleukin-17 neutralization
- (2011) Marije I. Koenders et al. ARTHRITIS AND RHEUMATISM
- Interleukin-23: as a drug target for autoimmune inflammatory diseases
- (2011) Chunlei Tang et al. IMMUNOLOGY
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Role of Th17 cells in human autoimmune arthritis
- (2010) Jan Leipe et al. ARTHRITIS AND RHEUMATISM
- Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
- (2010) Devesh Mewar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
- (2010) Steven S. Storage et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Structural basis of receptor sharing by interleukin 17 cytokines
- (2009) Lauren K Ely et al. NATURE IMMUNOLOGY
- IL-17 as a future therapeutic target for rheumatoid arthritis
- (2009) Wim B. van den Berg et al. Nature Reviews Rheumatology
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
- (2007) Erik Lubberts CYTOKINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now